Ken Fisher's position in Dexcom is currently worth $64.5 Million. That's 0.03% of their equity portfolio (187th largest holding). The first Dexcom trade was made in Q2 2020. Since then Ken Fisher bought shares eight more times and sold shares on ten occasions. The investor's estimated purchase price is $69.1 Million, resulting in a loss of 6.7%.